Goodgenes gone bad: a Short history of vaccines and biology: Failure, successes, controversies (Record no. 297523)

MARC details
000 -LEADER
fixed length control field 01855nam a22001457a 4500
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9780670096039
082 ## - DEWEY DECIMAL CLASSIFICATION NUMBER
Classification number 616.042
Item number CHI-G
100 ## - MAIN ENTRY--PERSONAL NAME
Personal name Chirmule, Narendra
245 ## - TITLE STATEMENT
Title Goodgenes gone bad: a Short history of vaccines and biology: Failure, successes, controversies
Statement of responsibility, etc. By Narendra Chirmule
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Place of publication, distribution, etc. India:
Name of publisher, distributor, etc. Ebury press,
Date of publication, distribution, etc. c2021.
300 ## - PHYSICAL DESCRIPTION
Extent i-xxxvi+202P.
505 ## - FORMATTED CONTENTS NOTE
Formatted contents note 1. The story of Haemophilia<br/>2: The Rotavirus Vaccine<br/>3: An Elusive Vaccine to Prevent AIDS<br/>4: The story of Immunotherapy<br/>5: The story of Cell therapy<br/>6: The story of Gene therapy<br/>7: Bicon and my own story of Biotechnology
520 ## - SUMMARY, ETC.
Summary, etc. The field of biotechnology has evolved over the past four decades, developing medicines which are curing diseases. But this journey of success has been tough and arduous, built upon the shoulders of major failures.<br/>Good Genes Gone Bad highlights seven such colossal failures in drug development-all of which culminated in the development of novel drugs-weaving together various analogies through the stories and thus allowing the reader to understand complex biological phenomena. These stories include treatment of medical conditions such as genetic clotting disorder (haemophilia), childhood-diarrhoea (rotavirus vaccine), preventing HIV infection, activation of the immune systems to treat cancer, gene therapy for treatment of diseases caused by gene-defects/mutations, cell therapy for treatment of leukaemias, and finally the success of Biocon’s approval of the first biologic drug for breast cancer.<br/>Written by the former R&D head of Biocon, India’s largest pharmaceutical company, Good Genes Gone Bad is a fascinating look at the complex world of medicine and drug development, providing the readers with a sense of magnitude of challenges and the extent of difficulty that it takes to make novel medicines.
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Koha item type Book
Holdings
Withdrawn status Lost status Damaged status Not for loan Home library Current library Shelving location Date acquired Total Checkouts Full call number Barcode Date last seen Date last checked out Price effective from Koha item type
        Dept. of Computational Biology and Bioinformatics Dept. of Computational Biology and Bioinformatics Processing Center 13/12/2021 1 616.042 CHI-G DCB4048 10/05/2022 11/02/2022 13/12/2021 Book